Table 2.
Attainment of care quality indicators from audit measures by peak stage AKI and for all episodes of AKI.
| Variables | AKI stage 2 | AKI stage 3 | All AKI (AKI stage 2 and 3) |
|---|---|---|---|
| Total N (%) | 498 (50.3) | 491 (49.6) | 989 (100.0) |
| Clinical assessment: Timely reviews N (%) | |||
| Consultant review within 6 h | 283 (58.0) | 288 (59.8) | 571 (58.9) |
| Medication review (dose adjustments and discontinuation within 6 h) | 392 (79.5) | 400 (82.1) | 792 (80.8) |
| Fluid balance assessment within 6 h | 425 (86.2) | 425 (87.5) | 850 (86.8) |
| Urinalysis test recorded | 173 (35.5) | 233 (48.3) | 406 (41.9) |
| Imaging of renal tract (within 24 or within 6 h if suspected pyonephrosis) | 139 (27.9) | 228 (46.5) | 367 (37.2) |
| Blood gas and acid bas recorded | 328 (66.3) | 372 (76.2) | 700 (71.2) |
| Clinical management: Timely interventions N (%) | |||
| Antibiotics within 1 h (indicated AKI stage 2 N=302, AKI stage 3 N=310) | 274 (90.7) | 271 (87.4) | 545 (89.1) |
| IV fluids (indicated AKI stage 2 N=400, AKI stage 3 N=398) | 384 (96.0) | 391 (98.2) | 775 (97.1) |
| Diuretics (indicated AKI stage 2 N=47, AKI stage 3 N=46) | 47 (100.0) | 45 (97.8) | 92 (98.9) |
| Bladder catheterisation (indicated AKI stage 2 N=226, AKI stage 3 N=299) | 210 (92.9) | 281 (94.0) | 491 (93.5) |
| Nephrostomy/Stent (indicated AKI stage 2 N=14, AKI stage 3 N=38) | 13 (92.9) | 33 (86.8) | 46 (88.5) |
| Follow-up and primary care communication N (%) | |||
| AKI mentioned on discharge letter (alive at discharge, AKI stage 2 N=357, AKI stage 3 N=325) | 250 (71.7) | 285 (87.7) | 541 (79.3) |
| Information on discharge letter to GP re medicine changes/review or recommended blood tests when applicable (indicated AKI stage 2 N=274, AKI stage 3 279) | 177 (64.6) | 187 (67.0) | 364 (65.8) |
| Follow-up of unresolved renal function mentioned on discharge letter (indicated AKI stage 2 169, AKI stage 3 201) | 98 (58.0) | 131 (65.2) | 229 (61.9) |